LLY vs IQV
By Alex · Tickerpine
Eli Lilly and Company vs IQVIA Holdings Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | IQV |
|---|---|---|
| Price | $1,184.78 | $270.97 |
| Market cap | $1.06T | $44.60B |
| P/E ratio | 39.7 | 33.7 |
| ROE | 102.29% | 22.82% |
| Profit margin | 33.53% | 8.10% |
| Revenue growth | 47.70% | 8.70% |
| Dividend yield | 0.58% | — |
| Beta | 0.50 | 1.19 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs IQV in plain English
- LLY is the bigger company — about 23.7× the market cap of IQV.
- IQV is cheaper on earnings (P/E 33.7 vs 39.7).
- LLY earns a higher return on equity (102% vs 23%).
- LLY is growing revenue faster (48% vs 9%).
- LLY pays a dividend (0.58%) while the other effectively doesn't.
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
IQV return calculator
See what $1,000 in IQVIA Holdings Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.